{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T02:03:34Z","timestamp":1775268214734,"version":"3.50.1"},"reference-count":87,"publisher":"Department of Medicine, Warren Alpert Medical School at Brown University","issue":"3","license":[{"start":{"date-parts":[[2022,8,26]],"date-time":"2022-08-26T00:00:00Z","timestamp":1661472000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:p>Diabetes mellitus and heart failure have a bidirectional relationship and can affect one another. Ventricular dysfunction that occurs in the absence of coronary atherosclerosis and hypertension in patients with diabetes mellitus is termed diabetic cardiomyopathy. Lipotoxicity, increased oxidative stress and mitochondrial dysfunction are a few of the mechanisms implicated in diabetic cardiomyopathy. Patients with diabetes mellitus undergo cardiac structural changes leading to heart failure. The novel glucose-lowering medication that is now preferred for diabetic patients with heart failure is the SGLT-2 (sodium-glucose cotransporter 2) inhibitor. Emerging targeted therapies are showing beneficial effects but require further evaluation. We review the literature describing the pathophysiology of diabetic cardiomyopathy, cardiac structural changes, along with the novel glucose-lowering therapies and targeted therapies for diabetic cardiomyopathy.<\/jats:p>","DOI":"10.56305\/001c.37850","type":"journal-article","created":{"date-parts":[[2022,8,29]],"date-time":"2022-08-29T15:11:37Z","timestamp":1661785897000},"source":"Crossref","is-referenced-by-count":8,"title":["Diabetic Cardiomyopathy: Pathophysiology and Novel Therapies"],"prefix":"10.56305","volume":"1","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2959-8937","authenticated-orcid":false,"given":"Sidhi","family":"Laksono","sequence":"first","affiliation":[{"name":"Siloam Diagram Heart Hospital, Cinere, Indonesia; Faculty of Medicine, Universitas Muhammadiyah Prof Dr Hamka, Tangerang, Indonesia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grace T.","family":"Hosea","sequence":"additional","affiliation":[{"name":"Pelita Harapan University, Tangerang, Indonesia","department":["Faculty of Medicine"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zahra","family":"Nurusshofa","sequence":"additional","affiliation":[{"name":"Universitas Muhammadiyah Prof Dr Hamka, Tangerang, Indonesia","department":["Faculty of Medicine"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"35509","published-online":{"date-parts":[[2022,8,26]]},"reference":[{"issue":"9786","key":"ref1","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/s0140-6736(11)60471-6","article-title":"Glycaemic control and incidence of heart failure in 20 985 patients with type 1 diabetes: an observational study","volume":"378","author":"Marcus Lind","year":"2011","journal-title":"The Lancet","ISSN":"https:\/\/id.crossref.org\/issn\/0140-6736","issn-type":"print"},{"issue":"8","key":"ref2","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1007\/s00125-014-3259-z","article-title":"Association of heart failure severity with risk of diabetes: a Danish nationwide cohort study","volume":"57","author":"Malene N. Demant","year":"2014","journal-title":"Diabetologia","ISSN":"https:\/\/id.crossref.org\/issn\/0012-186X","issn-type":"print"},{"issue":"2","key":"ref3","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1159\/000363282","article-title":"Heart failure as a risk factor for diabetes mellitus","volume":"129","author":"Maya Guglin","year":"2014","journal-title":"Cardiology","ISSN":"https:\/\/id.crossref.org\/issn\/0008-6312","issn-type":"print"},{"issue":"5","key":"ref4","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/j.amjhyper.2004.11.038","article-title":"The association of heart failure with insulin resistance and the development of type 2 diabetes","volume":"18","author":"J Kostis","year":"2005","journal-title":"American journal of hypertension","ISSN":"https:\/\/id.crossref.org\/issn\/0895-7061","issn-type":"print"},{"issue":"4","key":"ref5","doi-asserted-by":"publisher","first-page":"A146","DOI":"10.1016\/0735-1097(93)90480-o","article-title":"Comparative neurohormonal responses in patients with preserved and impaired left ventricular ejection fraction: Results of the studies of left ventricular dysfunctions (SOLVD) registry","volume":"22","author":"Claude R. Benedict","year":"1993","journal-title":"Journal of the American College of Cardiology","ISSN":"https:\/\/id.crossref.org\/issn\/0735-1097","issn-type":"print"},{"issue":"1","key":"ref6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12872-017-0551-0","article-title":"Advanced glycation end products in children with type 1 diabetes and early reduced diastolic heart function","volume":"17","author":"Leif Brunvand","year":"2017","journal-title":"BMC cardiovascular disorders","ISSN":"https:\/\/id.crossref.org\/issn\/1471-2261","issn-type":"print"},{"key":"ref7","first-page":"59","article-title":"The role of inflammation in diabetic cardiomyopathy","volume":"4","author":"S. Nunes","year":"2012","journal-title":"Int J Infereron Cytokine Mediator Res"},{"issue":"13","key":"ref8","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1016\/j.jacc.2012.11.062","article-title":"Association of epicardial fat with cardiovascular risk factors and incident myocardial infarction in the general population: the Heinz Nixdorf Recall Study","volume":"61","author":"Amir A. Mahabadi","year":"2013","journal-title":"Journal of the American College of Cardiology","ISSN":"https:\/\/id.crossref.org\/issn\/0735-1097","issn-type":"print"},{"issue":"5","key":"ref9","doi-asserted-by":"publisher","first-page":"177","DOI":"10.4239\/wjd.v4.i5.177","article-title":"Diabetic cardiomyopathy: Pathophysiology, diagnostic evaluation and management","volume":"4","author":"Joseph M Pappachan","year":"2013","journal-title":"World journal of diabetes","ISSN":"https:\/\/id.crossref.org\/issn\/1948-9358","issn-type":"print"},{"issue":"11","key":"ref10","doi-asserted-by":"publisher","first-page":"2780","DOI":"10.2337\/db06-1629","article-title":"Decreased L-type Ca2+ current in cardiac myocytes of type 1 diabetic Akita mice due to reduced phosphatidylinositol 3-kinase signaling","volume":"56","author":"Zhongju Lu","year":"2007","journal-title":"Diabetes","ISSN":"https:\/\/id.crossref.org\/issn\/0012-1797","issn-type":"print"},{"issue":"8","key":"ref11","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.2337\/diacare.27.8.1879","article-title":"The incidence of congestive heart failure in type 2 diabetes: an update","volume":"27","author":"Gregory A. Nichols","year":"2004","journal-title":"Diabetes care","ISSN":"https:\/\/id.crossref.org\/issn\/0149-5992","issn-type":"print"},{"issue":"3","key":"ref12","doi-asserted-by":"publisher","first-page":"608","DOI":"10.2337\/diabetes.55.03.06.db05-1284","article-title":"Mechanisms of [Ca2+] i transient decrease in cardiomyopathy of db\/db type 2 diabetic mice","volume":"55","author":"Laetitia Pereira","year":"2006","journal-title":"Diabetes","ISSN":"https:\/\/id.crossref.org\/issn\/0012-1797","issn-type":"print"},{"issue":"3","key":"ref13","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1113\/expphysiol.2010.055574","article-title":"Changing pattern of gene expression is associated with ventricular myocyte dysfunction and altered mechanisms of Ca<sup>2+<\/sup>signalling in young type 2 Zucker diabetic fatty rat heart","volume":"96","author":"F. C. Howarth","year":"2011","journal-title":"Experimental Physiology","ISSN":"https:\/\/id.crossref.org\/issn\/0958-0670","issn-type":"print"},{"issue":"1","key":"ref14","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s11010-011-1112-y","article-title":"Contractility of ventricular myocytes is well preserved despite altered mechanisms of Ca2+ transport and a changing pattern of mRNA in aged type 2 Zucker diabetic fatty rat heart","volume":"361","author":"F. C. Howarth","year":"2012","journal-title":"Molecular and cellular biochemistry","ISSN":"https:\/\/id.crossref.org\/issn\/0300-8177","issn-type":"print"},{"issue":"4","key":"ref15","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1097\/fjc.0b013e318228e68c","article-title":"Restoration of defective L-type Ca2+ current in cardiac myocytes of type 2 diabetic db\/db mice by Akt and PKC-\u03b9","volume":"58","author":"Zhongju Lu","year":"2011","journal-title":"Journal of cardiovascular pharmacology","ISSN":"https:\/\/id.crossref.org\/issn\/0160-2446","issn-type":"print"},{"issue":"11","key":"ref16","doi-asserted-by":"publisher","first-page":"3082","DOI":"10.2337\/diabetes.54.11.3082","article-title":"Effects of diabetes on ryanodine receptor Ca release channel (RyR2) and Ca2+ homeostasis in rat heart","volume":"54","author":"Nazmi Yaras","year":"2005","journal-title":"Diabetes","ISSN":"https:\/\/id.crossref.org\/issn\/0012-1797","issn-type":"print"},{"issue":"3","key":"ref17","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.diabres.2011.11.007","article-title":"Decrease in calcium-sensing receptor in the progress of diabetic cardiomyopathy","volume":"95","author":"Shu Zhi Bai","year":"2012","journal-title":"Diabetes research and clinical practice","ISSN":"https:\/\/id.crossref.org\/issn\/0168-8227","issn-type":"print"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/978-1-4419-9236-9_15","article-title":"Chronic diabetes alters function and expression of ryanodine receptor calcium-release channels in rat hearts","volume":"113-23","author":"Keshore R. Bidasee","year":"2003","journal-title":"Biochemistry of Diabetes and Atherosclerosis"},{"issue":"7471","key":"ref19","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1038\/nature12537","article-title":"Diabetic hyperglycaemia activates CaMKII and arrhythmias by O-linked glycosylation","volume":"502","author":"Jeffrey R. Erickson","year":"2013","journal-title":"Nature","ISSN":"https:\/\/id.crossref.org\/issn\/0028-0836","issn-type":"print"},{"issue":"3","key":"ref20","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/0891-5849(96)02051-5","article-title":"Low antioxidant enzyme gene expression in pancreatic islets compared with various other mouse tissues","volume":"20","author":"Slgurd Lenzen","year":"1996","journal-title":"Free Radical Biology and Medicine","ISSN":"https:\/\/id.crossref.org\/issn\/0891-5849","issn-type":"print"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.redox.2018.09.025","article-title":"New insights into oxidative stress and inflammation during diabetes mellitus-accelerated atherosclerosis","volume":"20","author":"Ting Yuan","year":"2019","journal-title":"Redox biology","ISSN":"https:\/\/id.crossref.org\/issn\/2213-2317","issn-type":"print"},{"issue":"12","key":"ref22","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1161\/circulationaha.106.658948","article-title":"Increasing cardiovascular disease burden due to diabetes mellitus: the Framingham Heart Study","volume":"115","author":"Caroline S. Fox","year":"2007","journal-title":"Circulation","ISSN":"https:\/\/id.crossref.org\/issn\/0009-7322","issn-type":"print"},{"issue":"6865","key":"ref23","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1038\/414813a","article-title":"Biochemistry and molecular cell biology of diabetic complications","volume":"414","author":"Michael Brownlee","year":"2001","journal-title":"Nature","ISSN":"https:\/\/id.crossref.org\/issn\/0028-0836","issn-type":"print"},{"issue":"3","key":"ref24","doi-asserted-by":"publisher","first-page":"234","DOI":"10.2174\/187152512802651097","article-title":"Aldose reductase, oxidative stress and diabetic cardiovascular complications","volume":"10","author":"Srinivasan Vedantham","year":"2012","journal-title":"Cardiovascular &amp; Hematological Agents in Medicinal Chemistry","ISSN":"https:\/\/id.crossref.org\/issn\/1871-5257","issn-type":"print"},{"issue":"11","key":"ref25","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1007\/s00109-005-0688-7","article-title":"Understanding RAGE, the receptor for advanced glycation end products","volume":"83","author":"Angelika Bierhaus","year":"2005","journal-title":"Journal of molecular medicine","ISSN":"https:\/\/id.crossref.org\/issn\/0946-2716","issn-type":"print"},{"issue":"5","key":"ref26","first-page":"2169","article-title":"Advanced glycation endproducts induce apoptosis of endothelial progenitor cells by activating receptor RAGE and NADPH oxidase\/JNK signaling axis","volume":"8","author":"J. Chen","year":"2016","journal-title":"American journal of translational research"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.pharmthera.2016.11.013","article-title":"Cardiac oxidative stress in diabetes: mechanisms and therapeutic potential","volume":"172","author":"Alyssa Faria","year":"2017","journal-title":"Pharmacology &amp; Therapeutics","ISSN":"https:\/\/id.crossref.org\/issn\/0163-7258","issn-type":"print"},{"issue":"1","key":"ref28","doi-asserted-by":"publisher","first-page":"C139","DOI":"10.1152\/ajpcell.00020.2010","article-title":"Hyperglycemia-mediated activation of the hexosamine biosynthetic pathway results in myocardial apoptosis","volume":"299","author":"Uthra Rajamani","year":"2010","journal-title":"American Journal of Physiology-Cell Physiology","ISSN":"https:\/\/id.crossref.org\/issn\/0363-6143","issn-type":"print"},{"issue":"9","key":"ref29","doi-asserted-by":"publisher","first-page":"3716","DOI":"10.1172\/jci120849","article-title":"Mitochondrial dysfunction in pathophysiology of heart failure","volume":"128","author":"Bo Zhou","year":"2018","journal-title":"Journal of Clinical Investigation","ISSN":"https:\/\/id.crossref.org\/issn\/0021-9738","issn-type":"print"},{"issue":"6","key":"ref30","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1161\/hypertensionaha.115.06015","article-title":"Endothelial mineralocorticoid receptor deletion prevents diet-induced cardiac diastolic dysfunction in females","volume":"66","author":"Guanghong Jia","year":"2015","journal-title":"Hypertension","ISSN":"https:\/\/id.crossref.org\/issn\/0194-911X","issn-type":"print"},{"issue":"2","key":"ref31","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.cmet.2015.01.005","article-title":"Altered myocardial calcium cycling and energetics in heart failure\u2014a rational approach for disease treatment","volume":"21","author":"Przemek A. Gorski","year":"2015","journal-title":"Cell metabolism","ISSN":"https:\/\/id.crossref.org\/issn\/1550-4131","issn-type":"print"},{"issue":"1","key":"ref32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbalip.2009.09.014","article-title":"Role of fatty acid uptake and fatty acid \u03b2-oxidation in mediating insulin resistance in heart and skeletal muscle","volume":"1801","author":"Liyan Zhang","year":"2010","journal-title":"Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids","ISSN":"https:\/\/id.crossref.org\/issn\/1388-1981","issn-type":"print"},{"issue":"4","key":"ref33","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jacc.2013.02.092","article-title":"A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation","volume":"62","author":"Walter J. Paulus","year":"2013","journal-title":"Journal of the American College of Cardiology","ISSN":"https:\/\/id.crossref.org\/issn\/0735-1097","issn-type":"print"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1097\/00019501-200511001-00003","article-title":"Rationale for a metabolic approach in diabetic coronary patients","volume":"16","author":"William C. Stanley","year":"2005","journal-title":"Coronary artery disease","ISSN":"https:\/\/id.crossref.org\/issn\/0954-6928","issn-type":"print"},{"issue":"4","key":"ref35","doi-asserted-by":"publisher","first-page":"H704","DOI":"10.1152\/ajpheart.00321.2017","article-title":"Cardiac performance is limited by oxygen delivery to the mitochondria in the crystalloid-perfused working heart","volume":"314","author":"Sarah Kuzmiak-Glancy","year":"2018","journal-title":"American Journal of Physiology-Heart and Circulatory Physiology","ISSN":"https:\/\/id.crossref.org\/issn\/0363-6135","issn-type":"print"},{"issue":"3","key":"ref36","first-page":"448","article-title":"Cardiac structure and function across the glycemic spectrum in elderly men and women free of prevalent heart disease: the Atherosclerosis Risk In the Community study","volume":"8","author":"H. Skali","year":"2015","journal-title":"Circulation: Heart Failure"},{"issue":"25","key":"ref37","doi-asserted-by":"publisher","first-page":"2148","DOI":"10.1016\/j.jacc.2008.09.014","article-title":"The relationship of left ventricular mass and geometry to incident cardiovascular events: the MESA (Multi-Ethnic Study of Atherosclerosis) study","volume":"52","author":"David A. Bluemke","year":"2008","journal-title":"Journal of the American College of Cardiology","ISSN":"https:\/\/id.crossref.org\/issn\/0735-1097","issn-type":"print"},{"issue":"9","key":"ref38","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1097\/00004872-200109000-00021","article-title":"Progression of functional and structural cardiac alterations in young normotensive uncomplicated patients with type 1 diabetes mellitus","volume":"19","author":"Stefano Carugo","year":"2001","journal-title":"Journal of hypertension","ISSN":"https:\/\/id.crossref.org\/issn\/0263-6352","issn-type":"print"},{"issue":"7","key":"ref39","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1016\/j.amjcard.2003.12.026","article-title":"Prevalence of ventricular diastolic dysfunction in asymptomatic, normotensive patients with diabetes mellitus","volume":"93","author":"John K Boyer","year":"2004","journal-title":"The American journal of cardiology","ISSN":"https:\/\/id.crossref.org\/issn\/0002-9149","issn-type":"print"},{"issue":"3","key":"ref40","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.pharmthera.2014.01.003","article-title":"Diabetic cardiomyopathy: mechanisms and new treatment strategies targeting antioxidant signaling pathways","volume":"142","author":"Karina Huynh","year":"2014","journal-title":"Pharmacology &amp; Therapeutics","ISSN":"https:\/\/id.crossref.org\/issn\/0163-7258","issn-type":"print"},{"issue":"12","key":"ref41","first-page":"1321","article-title":"Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"17","author":"S.F. Nagueh","year":"2016","journal-title":"European Journal of Echocardiography"},{"issue":"1","key":"ref42","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1161\/circulationaha.107.728550","article-title":"Diastolic stiffness of the failing diabetic heart: importance of fibrosis, advanced glycation end products, and myocyte resting tension","volume":"117","author":"Loek van Heerebeek","year":"2008","journal-title":"Circulation","ISSN":"https:\/\/id.crossref.org\/issn\/0009-7322","issn-type":"print"},{"key":"ref43","first-page":"767","article-title":"Myocyte death and growth in the failing heart","volume":"78","author":"P. Anversa","year":"1998","journal-title":"Lab Invest"},{"issue":"27","key":"ref44","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1093\/eurheartj\/ehv134","article-title":"Clinical diabetic cardiomyopathy: a two-faced disease with restrictive and dilated phenotypes","volume":"36","author":"Petar M. Seferovi\u0107","year":"2015","journal-title":"European heart journal","ISSN":"https:\/\/id.crossref.org\/issn\/0195-668X","issn-type":"print"},{"issue":"12","key":"ref45","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1111\/j.1464-5491.2005.01685.x","article-title":"Early detection of diabetic cardiomyopathy: usefulness of tissue Doppler imaging","volume":"22","author":"P. Di Bonito","year":"2005","journal-title":"Diabetic Medicine","ISSN":"https:\/\/id.crossref.org\/issn\/0742-3071","issn-type":"print"},{"issue":"11","key":"ref46","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1016\/j.echo.2011.07.017","article-title":"Diastolic dysfunction in patients with type 2 diabetes mellitus: is it really the first marker of diabetic cardiomyopathy?","volume":"24","author":"Laura Ernande","year":"2011","journal-title":"Journal of the American Society of Echocardiography","ISSN":"https:\/\/id.crossref.org\/issn\/0894-7317","issn-type":"print"},{"issue":"9","key":"ref47","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.3109\/10715762.2015.1050587","article-title":"<i>In vivo<\/i>targeted molecular magnetic resonance imaging of free radicals in diabetic cardiomyopathy within mice","volume":"49","author":"R. A. Towner","year":"2015","journal-title":"Free Radical Research","ISSN":"https:\/\/id.crossref.org\/issn\/1071-5762","issn-type":"print"},{"issue":"4","key":"ref48","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1056\/nejmoa1603827","article-title":"Liraglutide and cardiovascular outcomes in type 2 diabetes","volume":"375","author":"Steven P. Marso","year":"2016","journal-title":"New England Journal of Medicine","ISSN":"https:\/\/id.crossref.org\/issn\/0028-4793","issn-type":"print"},{"issue":"22","key":"ref49","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1056\/nejmoa1504720","article-title":"Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes","volume":"373","author":"Bernard Zinman","year":"2015","journal-title":"New England Journal of Medicine","ISSN":"https:\/\/id.crossref.org\/issn\/0028-4793","issn-type":"print"},{"issue":"13","key":"ref50","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1056\/nejmoa1612917","article-title":"Effects of once-weekly exenatide on cardiovascular outcomes in type 2 diabetes","volume":"377","author":"Rury R. Holman","year":"2017","journal-title":"New England Journal of Medicine","ISSN":"https:\/\/id.crossref.org\/issn\/0028-4793","issn-type":"print"},{"issue":"23","key":"ref51","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1056\/nejmoa1509225","article-title":"Lixisenatide in patients with type 2 diabetes and acute coronary syndrome","volume":"373","author":"Marc A. Pfeffer","year":"2015","journal-title":"New England Journal of Medicine","ISSN":"https:\/\/id.crossref.org\/issn\/0028-4793","issn-type":"print"},{"issue":"4","key":"ref52","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1056\/nejmoa1603827","article-title":"Liraglutide and cardiovascular outcomes in type 2 diabetes","volume":"375","author":"Steven P. Marso","year":"2016","journal-title":"New England Journal of Medicine","ISSN":"https:\/\/id.crossref.org\/issn\/0028-4793","issn-type":"print"},{"issue":"19","key":"ref53","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1056\/nejmoa1607141","article-title":"Semaglutide and cardiovascular outcomes in patients with type 2 diabetes","volume":"375","author":"Steven P. Marso","year":"2016","journal-title":"New England Journal of Medicine","ISSN":"https:\/\/id.crossref.org\/issn\/0028-4793","issn-type":"print"},{"issue":"4","key":"ref54","doi-asserted-by":"publisher","first-page":"e12763","DOI":"10.1111\/acel.12763","article-title":"Glucagon-like peptide-1 ameliorates cardiac lipotoxicity in diabetic cardiomyopathy via the PPAR\u03b1 pathway","volume":"17","author":"Lujin Wu","year":"2018","journal-title":"Aging Cell","ISSN":"https:\/\/id.crossref.org\/issn\/1474-9718","issn-type":"print"},{"issue":"16","key":"ref55","doi-asserted-by":"publisher","first-page":"e147","DOI":"10.1161\/cir.0b013e31829e8776","article-title":"ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"62","author":"Clyde W. Yancy","year":"2013","journal-title":"Circulation","ISSN":"https:\/\/id.crossref.org\/issn\/0009-7322","issn-type":"print"},{"issue":"5","key":"ref56","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1001\/jama.2016.10260","article-title":"Effects of liraglutide on clinical stability among patients with advanced heart failure and reduced ejection fraction: a randomized clinical trial","volume":"316","author":"Kenneth B. Margulies","year":"2016","journal-title":"Jama","ISSN":"https:\/\/id.crossref.org\/issn\/0098-7484","issn-type":"print"},{"issue":"1","key":"ref57","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1002\/ejhf.657","article-title":"Effect of liraglutide, a glucagon-like peptide-1 analogue, on left ventricular function in stable chronic heart failure patients with and without diabetes (LIVE)\u2014a multicentre, double-blind, randomised, placebo-controlled trial","volume":"19","author":"Anders Jorsal","year":"2017","journal-title":"European journal of heart failure","ISSN":"https:\/\/id.crossref.org\/issn\/1388-9842","issn-type":"print"},{"issue":"22","key":"ref58","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1056\/nejmoa1504720","article-title":"Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes","volume":"373","author":"Bernard Zinman","year":"2015","journal-title":"New England Journal of Medicine","ISSN":"https:\/\/id.crossref.org\/issn\/0028-4793","issn-type":"print"},{"issue":"7","key":"ref59","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1056\/nejmoa1611925","article-title":"Canagliflozin and cardiovascular and renal events in type 2 diabetes","volume":"377","author":"Bruce Neal","year":"2017","journal-title":"New England Journal of Medicine","ISSN":"https:\/\/id.crossref.org\/issn\/0028-4793","issn-type":"print"},{"issue":"10","key":"ref60","doi-asserted-by":"publisher","first-page":"2098","DOI":"10.1007\/s00125-018-4669-0","article-title":"The actions of SGLT2 inhibitors on metabolism, renal function and blood pressure","volume":"61","author":"Merlin C. Thomas","year":"2018","journal-title":"Diabetologia","ISSN":"https:\/\/id.crossref.org\/issn\/0012-186X","issn-type":"print"},{"issue":"14","key":"ref61","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1056\/nejmoa1307684","article-title":"Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus","volume":"369","author":"Benjamin M. Scirica","year":"2013","journal-title":"New England Journal of Medicine","ISSN":"https:\/\/id.crossref.org\/issn\/0028-4793","issn-type":"print"},{"issue":"1","key":"ref62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12968-015-0198-x","article-title":"Time course of cardiometabolic alterations in a high fat high sucrose diet mice model and improvement after GLP-1 analog treatment using multimodal cardiovascular magnetic resonance","volume":"17","author":"In\u00e8s Abdesselam","year":"2015","journal-title":"Journal of Cardiovascular Magnetic Resonance","ISSN":"https:\/\/id.crossref.org\/issn\/1532-429X","issn-type":"print"},{"issue":"9982","key":"ref63","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1016\/s0140-6736(14)62225-x","article-title":"Heart failure and mortality outcomes in patients with type 2 diabetes taking alogliptin versus placebo in EXAMINE: a multicentre, randomised, double-blind trial","volume":"385","author":"Faiez Zannad","year":"2015","journal-title":"The Lancet","ISSN":"https:\/\/id.crossref.org\/issn\/0140-6736","issn-type":"print"},{"issue":"3","key":"ref64","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1056\/nejmoa1501352","article-title":"Effect of sitagliptin on cardiovascular outcomes in type 2 diabetes","volume":"373","author":"Jennifer B. Green","year":"2015","journal-title":"New England Journal of Medicine","ISSN":"https:\/\/id.crossref.org\/issn\/0028-4793","issn-type":"print"},{"issue":"11","key":"ref65","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1161\/circresaha.116.306924","article-title":"Heart failure considerations of antihyperglycemic medications for type 2 diabetes","volume":"118","author":"Eberhard Standl","year":"2016","journal-title":"Circulation research","ISSN":"https:\/\/id.crossref.org\/issn\/0009-7330","issn-type":"print"},{"issue":"39","key":"ref66","doi-asserted-by":"publisher","first-page":"3035","DOI":"10.1093\/eurheartj\/eht108","article-title":"2019 ESC guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASDThe task force for diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and the European Association for the Study of Diabetes (EASD)","volume":"34","author":"F. Cosentino","year":"2013","journal-title":"European Heart Journal","ISSN":"https:\/\/id.crossref.org\/issn\/0195-668X","issn-type":"print"},{"issue":"2","key":"ref67","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1093\/eurheartj\/ehz486","article-title":"2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: The Task Force for diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and the European Association for the Study of Diabetes (EASD)","volume":"41","author":"Francesco Cosentino","year":"2020","journal-title":"European Heart Journal","ISSN":"https:\/\/id.crossref.org\/issn\/0195-668X","issn-type":"print"},{"issue":"11","key":"ref68","doi-asserted-by":"publisher","first-page":"2773","DOI":"10.2337\/dc07-0717","article-title":"Pioglitazone use and heart failure in patients with type 2 diabetes and preexisting cardiovascular disease: data from the PROactive study (PROactive 08)","volume":"30","author":"Erland Erdmann","year":"2007","journal-title":"Diabetes Care","ISSN":"https:\/\/id.crossref.org\/issn\/0149-5992","issn-type":"print"},{"issue":"1","key":"ref69","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1093\/cvr\/cvr145","article-title":"MicroRNA-195 promotes palmitate-induced apoptosis in cardiomyocytes by down-regulating Sirt1","volume":"92","author":"Huaqing Zhu","year":"2011","journal-title":"Cardiovascular research","ISSN":"https:\/\/id.crossref.org\/issn\/1755-3245","issn-type":"print"},{"issue":"10","key":"ref70","doi-asserted-by":"publisher","first-page":"e1479","DOI":"10.1038\/cddis.2014.430","article-title":"MicroRNA-30d regulates cardiomyocyte pyroptosis by directly targeting foxo3a in diabetic cardiomyopathy","volume":"5","author":"X Li","year":"2014","journal-title":"Cell Death &amp; Disease","ISSN":"https:\/\/id.crossref.org\/issn\/2041-4889","issn-type":"print"},{"issue":"1","key":"ref71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12933-018-0767-z","article-title":"MiR-21 protected against diabetic cardiomyopathy induced diastolic dysfunction by targeting gelsolin","volume":"17","author":"Beibei Dai","year":"2018","journal-title":"Cardiovascular diabetology","ISSN":"https:\/\/id.crossref.org\/issn\/1475-2840","issn-type":"print"},{"issue":"8","key":"ref72","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.1016\/j.bbadis.2017.03.013","article-title":"Role of microRNA in diabetic cardiomyopathy: from mechanism to intervention","volume":"1863","author":"Rui Guo","year":"2017","journal-title":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","ISSN":"https:\/\/id.crossref.org\/issn\/0925-4439","issn-type":"print"},{"issue":"6","key":"ref73","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1093\/eurheartj\/ehp573","article-title":"microRNAs in heart disease: putative novel therapeutic targets?","volume":"31","author":"G. Condorelli","year":"2010","journal-title":"European heart journal","ISSN":"https:\/\/id.crossref.org\/issn\/0195-668X","issn-type":"print"},{"issue":"21","key":"ref74","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.1016\/j.jacc.2014.01.050","article-title":"microRNAs in cardiovascular diseases: current knowledge and the road ahead","volume":"63","author":"Gianluigi Condorelli","year":"2014","journal-title":"Journal of the American College of Cardiology","ISSN":"https:\/\/id.crossref.org\/issn\/0735-1097","issn-type":"print"},{"issue":"1","key":"ref75","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms2090","article-title":"The miRNA-212\/132 family regulates both cardiac hypertrophy and cardiomyocyte autophagy","volume":"3","author":"Ahmet Ucar","year":"2012","journal-title":"Nature communications","ISSN":"https:\/\/id.crossref.org\/issn\/2041-1723","issn-type":"print"},{"issue":"6","key":"ref76","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.2337\/diabetes.54.6.1829","article-title":"Inhibition of superoxide generation and associated nitrosative damage is involved in metallothionein prevention of diabetic cardiomyopathy","volume":"54","author":"Lu Cai","year":"2005","journal-title":"Diabetes","ISSN":"https:\/\/id.crossref.org\/issn\/0012-1797","issn-type":"print"},{"issue":"4","key":"ref77","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1161\/circresaha.117.311586","article-title":"Diabetic Cardiomyopathy: An Update of Mechanisms Contributing to This Clinical Entity","volume":"122","author":"Guanghong Jia","year":"2018","journal-title":"Circulation Research","ISSN":"https:\/\/id.crossref.org\/issn\/0009-7330","issn-type":"print"},{"issue":"8","key":"ref78","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1016\/j.jacc.2006.07.022","article-title":"Attenuation by metallothionein of early cardiac cell death via suppression of mitochondrial oxidative stress results in a prevention of diabetic cardiomyopathy","volume":"48","author":"Lu Cai","year":"2006","journal-title":"Journal of the American College of Cardiology","ISSN":"https:\/\/id.crossref.org\/issn\/0735-1097","issn-type":"print"},{"issue":"11","key":"ref79","doi-asserted-by":"publisher","first-page":"8463","DOI":"10.1074\/jbc.m109.051714","article-title":"Activation of NRF2 by nitrosative agents and H2O2 involves KEAP1 disulfide formation","volume":"285","author":"Simon Fourquet","year":"2010","journal-title":"Journal of Biological Chemistry","ISSN":"https:\/\/id.crossref.org\/issn\/0021-9258","issn-type":"print"},{"key":"ref80","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/260429","article-title":"The Role of Nrf2-Mediated Pathway in Cardiac Remodeling and Heart Failure","volume":"2014","author":"Shanshan Zhou","year":"2014","journal-title":"Oxidative Medicine and Cellular Longevity","ISSN":"https:\/\/id.crossref.org\/issn\/1942-0900","issn-type":"print"},{"issue":"6","key":"ref81","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1016\/j.biotechadv.2017.12.015","article-title":"Activation of Nrf2 signaling by natural products-can it alleviate diabetes?","volume":"36","author":"Manuel Matzinger","year":"2018","journal-title":"Biotechnology advances","ISSN":"https:\/\/id.crossref.org\/issn\/0734-9750","issn-type":"print"},{"key":"ref82","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/9372182","article-title":"Activators and Inhibitors of NRF2: A Review of Their Potential for Clinical Development","volume":"2019","author":"Natalia Robledinos-Ant\u00f3n","year":"2019","journal-title":"Oxidative Medicine and Cellular Longevity","ISSN":"https:\/\/id.crossref.org\/issn\/1942-0900","issn-type":"print"},{"issue":"6","key":"ref83","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.3390\/ijms20061273","article-title":"Effective treatment of diabetic cardiomyopathy and heart failure with reconstituted HDL (Milano) in mice","volume":"20","author":"Joseph Aboumsallem","year":"2019","journal-title":"International Journal of Molecular Sciences","ISSN":"https:\/\/id.crossref.org\/issn\/1422-0067","issn-type":"print"},{"issue":"17","key":"ref84","doi-asserted-by":"publisher","first-page":"6043","DOI":"10.3390\/ijms21176043","article-title":"Mitochondrial Dysfunction in Diabetic Cardiomyopathy: The Possible Therapeutic Roles of Phenolic Acids","volume":"21","author":"Fatin Farhana Jubaidi","year":"2020","journal-title":"International Journal of Molecular Sciences","ISSN":"https:\/\/id.crossref.org\/issn\/1422-0067","issn-type":"print"},{"issue":"10","key":"ref85","doi-asserted-by":"publisher","first-page":"976","DOI":"10.2174\/1389203720666190726152847","article-title":"Bile Acids and Farnesoid X Receptor: Novel Target for the Treatment of Diabetic Cardiomyopathy","volume":"20","author":"Chao Li","year":"2019","journal-title":"Current Protein &amp; Peptide Science","ISSN":"https:\/\/id.crossref.org\/issn\/1389-2037","issn-type":"print"},{"issue":"2","key":"ref86","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/s2213-8587(14)70219-0","article-title":"Type 2 diabetes and incidence of cardiovascular diseases: a cohort study in 1\u00b79 million people","volume":"3","author":"Anoop Dinesh Shah","year":"2015","journal-title":"The Lancet Diabetes &amp; Endocrinology","ISSN":"https:\/\/id.crossref.org\/issn\/2213-8587","issn-type":"print"},{"issue":"3","key":"ref87","doi-asserted-by":"publisher","first-page":"612","DOI":"10.2337\/diacare.28.3.612","article-title":"The association between glucose abnormalities and heart failure in the population-based Reykjavik study","volume":"28","author":"Inga S. Thrainsdottir","year":"2005","journal-title":"Diabetes care","ISSN":"https:\/\/id.crossref.org\/issn\/0149-5992","issn-type":"print"}],"container-title":["Journal of Brown Hospital Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/bhm.scholasticahq.com\/article\/37850-diabetic-cardiomyopathy-pathophysiology-and-novel-therapies","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T18:13:52Z","timestamp":1739902432000},"score":1,"resource":{"primary":{"URL":"https:\/\/bhm.scholasticahq.com\/article\/37850-diabetic-cardiomyopathy-pathophysiology-and-novel-therapies"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,26]]},"references-count":87,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.56305\/001c.37850","relation":{},"ISSN":["2994-5593"],"issn-type":[{"value":"2994-5593","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,26]]}}}